Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 15-May 2019. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 112689901000001111 | Carmustine Obvius 100mg powder and solvent for concentrate for solution for infusion vials (Nexcape Pharmaceuticals Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 112690001000001119 | Carmustine Obvius 100mg powder and solvent for concentrate for solution for infusion vials (Nexcape Pharmaceuticals Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Carmustine Obvius 100mg powder and solvent for concentrate for solution for infusion vials (Nexcape Pharmaceuticals Ltd) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | false | Inferred relationship | Existential restriction modifier | ||
| Carmustine Obvius 100mg powder and solvent for concentrate for solution for infusion vials (Nexcape Pharmaceuticals Ltd) | Is a | Carmustine 100mg powder and solvent for solution for injection vials | false | Inferred relationship | Existential restriction modifier | ||
| Carmustine Obvius 100mg powder and solvent for concentrate for solution for infusion vials (Nexcape Pharmaceuticals Ltd) | Has active ingredient | Carmustine | false | Inferred relationship | Existential restriction modifier | ||
| Carmustine Obvius 100mg powder and solvent for concentrate for solution for infusion vials (Nexcape Pharmaceuticals Ltd) | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Carmustine Obvius 100mg powder and solvent for concentrate for solution for infusion vials (Nexcape Pharmaceuticals Ltd) | VMP non-availability indicator | Re-introduced | false | Inferred relationship | Existential restriction modifier | ||
| Carmustine Obvius 100mg powder and solvent for concentrate for solution for infusion vials (Nexcape Pharmaceuticals Ltd) | Has specific active ingredient | Carmustine | false | Inferred relationship | Existential restriction modifier | ||
| Carmustine Obvius 100mg powder and solvent for concentrate for solution for infusion vials (Nexcape Pharmaceuticals Ltd) | Has dispensed dose form | Powder and solvent for solution for infusion | false | Inferred relationship | Existential restriction modifier | ||
| Carmustine Obvius 100mg powder and solvent for concentrate for solution for infusion vials (Nexcape Pharmaceuticals Ltd) | Has excipient | Excipient not declared | false | Inferred relationship | Existential restriction modifier | ||
| Carmustine Obvius 100mg powder and solvent for concentrate for solution for infusion vials (Nexcape Pharmaceuticals Ltd) | Is a | Actual medicinal product | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Carmustine Obvius 100mg powder and solvent for concentrate for solution for infusion vials (Nexcape Pharmaceuticals Ltd) 1 vial | Has AMP | False | Carmustine Obvius 100mg powder and solvent for concentrate for solution for infusion vials (Nexcape Pharmaceuticals Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR